Stay updated on Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial
Sign up to get notified when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.

Latest updates to the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the Record History.SummaryDifference0.1%

- Check21 days agoChange DetectedA new revision entry v3.4.3 appears in the Study Record Versions, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and older government-funding notices were removed. These are administrative updates to the page history and do not affect the study record content.SummaryDifference0.9%

- Check57 days agoChange DetectedA site-wide notice about government funding and NIH Clinical Center status was added, with a link to opm.gov. The history also shows Revision: v3.4.1 added and Revision: v3.4.0 removed.SummaryDifference0.9%

- Check64 days agoChange DetectedUI updates include a 'Show glossary' option and color-coded change highlights (green for additions, red for deletions) with a new revision note (v3.4.0). The older revision note (v3.3.4) and related labeling appear to be superseded.SummaryDifference1%

- Check78 days agoChange DetectedRecord History shows a new revision from v3.3.3 to v3.3.4, indicating a minor site version update rather than changes to trial content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.